Allergy Therapeutics PLC Stock
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | 0.000% | -1.786% | -11.290% | 64.179% | -5.983% | 131.579% | -50.450% |
| Beximco Pharmaceuticals Ltd. GDR | 5.000% | -12.000% | -14.563% | -2.222% | -1.786% | 5.769% | -55.779% |
| Eledon Pharmaceuticals Inc. | 4.000% | 0.000% | 19.048% | -10.072% | 95.313% | 42.857% | -71.264% |
| SELLAS Life Sciences Group Inc | 8.510% | -5.906% | -21.295% | 275.393% | 26.455% | 164.771% | -53.532% |
News
Should You Buy AT&T Stock Before April 22?
A big potential catalyst for any stock is always its quarterly earnings report, which can give investors a good indication of whether its business is on the right path or not. If a company posts
3 Recession-Proof Stocks to Buy Before the Next Market Crash
These are trying times for growth investors, so maybe it's a good time to be trying something different. You know those all-weather defensive stocks that many have been rotating into these days
Stock Market Today, March 19: AT&T Rises After Launch of AI-Powered Customer App
AT&T (NYSE:T), a provider of wireless and broadband services in the U.S, closed Thursday at $27.77, up 1.30%. The stock is rising after coverage of its new AI-heavy customer app and 2025 digital


